Breakthrough Therapies NTRK With Robert Doebele

Published: March 15, 2022, 2 p.m.

In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.